Cargando…
MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C
OBJECT: Non-small lung cancer (NSCLC), with a poor 5-year survival rate (16%), is the major type of lung cancer. Metastasis has been identified as the main factor that leads to NSCLC therapy failure. MiR-206 is a metastasis suppressor in many cancers, including colorectal cancer, renal cell carcinom...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079403/ https://www.ncbi.nlm.nih.gov/pubmed/32206066 http://dx.doi.org/10.1186/s11658-020-00216-x |